Prevail Therapeutics
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease (NCT06565195) | Prevail Therapeutics | 2024-08-27 |
| A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED) (NCT05487599) | Prevail Therapeutics | 2022-12-20 |
| Phase 1/2 Clinical Trial of PR001 in Infants With Type 2 Gaucher Disease (PROVIDE) (NCT04411654) | Prevail Therapeutics | 2021-06-29 |
| Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN) (NCT04408625) | Prevail Therapeutics | 2020-11-09 |
| Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL) (NCT04127578) | Prevail Therapeutics | 2020-01-03 |
Track Prevail Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.